Hybrigen, Inc.

Hybrigen's two-hybrid technologies transform the two-hybrid experience from one of mixed success and frustrating results to an incredibly powerful, consistent tool for pathway exploration.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Proteins

Therapeutic targets:

- Cancer
- Oncology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Australia/New-Zealand , Asia

c. Countries active: USA, Australia, Canada, UK, Germany, France, Russia, Japan

Corporate data:

Number of Employees: 20

Turnover:

Amount:	Year:	Currency:
1	2001	US Dollar

Year founded: 1997